Deep learning models for deriving optimised measures of fat and muscle mass from MRI.

Journal: Scientific reports
Published Date:

Abstract

Fat and muscle mass are potential biomarkers of wellbeing and disease in oncology, but clinical measurement methods vary considerably. Here we evaluate the accuracy, precision and ability to track change for multiple deep learning (DL) models that quantify fat and muscle mass from abdominal MRI. Specifically, subcutaneous fat (SF), intra-abdominal fat (VF), external muscle (EM) and psoas muscle (PM) were evaluated using 15 convolutional neural network (CNN)-based and 4 transformer-based deep learning model architectures. There was negligible difference in the accuracy of human observers and all deep learning models in delineating SF or EM. Both of these tissues had excellent repeatability of their delineation. VF was measured most accurately by the human observers, then by CNN-based models, which outperformed transformer-based models. In distinction, PM delineation accuracy and repeatability was poor for all assessments. Repeatability limits of agreement determined when changes measured in individual patients were due to real change rather than test-retest variation. In summary, DL model accuracy and precision of delineating fat and muscle volumes varies between CNN-based and transformer-based models, between different tissues and in some cases with gender. These factors should be considered when investigators deploy deep learning methods to estimate biomarkers of fat and muscle mass.

Authors

  • Belvin Thomas
    Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. belvin.thomas@icr.ac.uk.
  • M Adam Ali
    Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
  • Fatima M H Ali
    Radiology Department, Northwick Park Hospital, Harrow, UK.
  • Anthony Chung
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Manjiri Joshi
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Sophia Maiguma-Wilson
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Gabrielle Reiff
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Hadil Said
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Pardis Zalmay
    Radiology Department, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Michael Berks
    Centre for Imaging Sciences, Division of Informatics, Imaging & Data Sciences, The University of Manchester, Manchester, UK.
  • Matthew D Blackledge
    Division of Radiotherapy and Imaging, the Institute of Cancer, London, SM2 5NG, UK. matthew.blackledge@icr.ac.uk.
  • James P B O'Connor
    From the Department of Radiology, Royal Marsden Hospital NHS Foundation Trust, Sutton, England (J.D.S., D.a.D., K.D., N. P., C.M., D.M.K.); Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, England (S.J.D., S.K., J.P.B.O., N. P., C.M., D.M.K., M.R.O.); and Computational Clinical Imaging Group, Champalimaud Foundation, Centre for the Unknown, Lisbon, Portugal (N.P.).